Literature DB >> 17909319

Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answer.

Stephen D Lawn, Robin Wood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909319     DOI: 10.1097/QAI.0b013e3181398d28

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

1.  Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi.

Authors:  M van Lettow; A K Chan; A S Ginsburg; H Tweya; D Gareta; J Njala; H Kanyerere; S Phiri; I Idana
Journal:  Public Health Action       Date:  2011-09-21

Review 2.  Tuberculosis and HIV co-infection: screening and treatment strategies.

Authors:  Kartik K Venkatesh; Soumya Swaminathan; Jason R Andrews; Kenneth H Mayer
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

Review 3.  Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections.

Authors:  Stephen D Lawn; M Estée Török; Robin Wood
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

Review 4.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

Review 5.  Management of individuals requiring antiretroviral therapy and TB treatment.

Authors:  Karen Cohen; Graeme Meintjes
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

6.  Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy.

Authors:  Stephen D Lawn; Robin Wood
Journal:  Clin Infect Dis       Date:  2011-06       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.